NasdaqGS:TWSTBiotechs
Twist Bioscience (TWST) Stock Could Be Overvalued Even After A 261% Run
Twist Bioscience stock has delivered a very strong 261.2% return over the past 3 years, yet the broader valuation checks point to a company that currently appears expensive rather than obviously cheap. That tension between a powerful share price run and a low value score is what investors now have to weigh.
Twist Bioscience's 261.2% return over 3 years highlights how much optimism is already reflected in the share price.
Expectations around the company turning its science into durable...